Home531752 • BOM
add
Biogen Pharmachem Industries Ltd
Nakaraang pagsara
₹1.27
Sakop ng araw
₹1.23 - ₹1.31
Sakop ng taon
₹0.79 - ₹1.85
Market cap
782.64M INR
Average na Volume
1.68M
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | -6.50M | -185.97% |
Gastos sa pagpapatakbo | 3.47M | 852.75% |
Net na kita | -9.97M | -238.46% |
Net profit margin | 153.31 | 61.06% |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.23M | 1,636.02% |
Kabuuang asset | 554.56M | -9.86% |
Kabuuang sagutin | 909.00K | -98.43% |
Kabuuang equity | 553.65M | — |
Natitirang share | 498.65M | — |
Presyo para makapag-book | 1.14 | — |
Return on assets | — | — |
Return on capital | -4.46% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.97M | -238.46% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Itinatag
1995
Website
